We are live on ! Find out more
Ken Griffin

Ken Griffin Citadel Advisors

AUM $875B
1-Year Est. Return 40.91%
 

Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.

This Fund
S&P 500
This Quarter Est. Return
-13.42%
1 Year Est. Return
+40.91%
3 Year Est. Return
+115.85%
5 Year Est. Return
+132.1%
10 Year Est. Return
+518.81%
AUM
$390B
AUM Growth
-$94.7B
Cap. Flow
+$10.4B
Cap. Flow %
2.66%
Top 10 Hldgs %
28.21%
Holding
14,957
New
1,520
Increased
5,503
Reduced
5,522
Closed
2,191

Sector Composition

Rank Sector Weight
1 Healthcare 2.83%
2 Technology 2.79%
3 Financials 2.29%
4 Consumer Discretionary 1.93%
5 Industrials 1.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ACIC icon
11026
American Coastal Insurance
ACIC
$466M
$130K ﹤0.01%
83,295
+11,173
+15% +$23.7K
ALLK
11027
CALL
DELISTED
Allakos
ALLK
$130K ﹤0.01%
41,500
-47,400
-53% -$177K
ARHS icon
11028
CALL
Arhaus
ARHS
$1.39B
$130K ﹤0.01%
+28,800
New +$189K
CION icon
11029
CION Investment
CION
$370M
$130K ﹤0.01%
+14,952
New +$161K
DRIO icon
11030
CALL
DarioHealth
DRIO
$74.3M
$130K ﹤0.01%
1,055
-70
-6% -$8.21K
NGD
11031
PUT
DELISTED
New Gold Inc
NGD
$130K ﹤0.01%
121,200
-5,900
-5% -$8.44K
RIGL icon
11032
CALL
Rigel Pharmaceuticals
RIGL
$795M
$130K ﹤0.01%
11,460
+2,770
+32% +$55.6K
TK icon
11033
PUT
Teekay
TK
$1.09B
$130K ﹤0.01%
45,300
+16,900
+60% +$55.3K
VKTX icon
11034
PUT
Viking Therapeutics
VKTX
$3.87B
$130K ﹤0.01%
45,000
-16,800
-27% -$41.6K
WT icon
11035
CALL
WisdomTree
WT
$3.46B
$130K ﹤0.01%
25,600
-5,400
-17% -$31K
VGR
11036
PUT
DELISTED
Vector Group Ltd.
VGR
$130K ﹤0.01%
12,400
+300
+2% +$3.6K
ALLG
11037
DELISTED
Allego N.V.
ALLG
$130K ﹤0.01%
25,581
-18,042
-41% -$165K
PMGMU
11038
DELISTED
Priveterra Acquisition Corp. Units
PMGMU
$130K ﹤0.01%
13,254
+100
+0.8% +$985
ALTIW
11039
DELISTED
AlTi Global Inc Warrant
ALTIW
$130K ﹤0.01%
200,001
-91,665
-31% -$55.9K
RAAS
11040
DELISTED
Cloopen Group Holding Limited American Depositary Shares (each representing six (6) Class A Ordinary Shares)
RAAS
$130K ﹤0.01%
41,146
-26,848
-39% -$86.6K
ATOS icon
11041
CALL
Atossa Therapeutics
ATOS
$25.9M
$129K ﹤0.01%
7,920
-2,373
-23% -$37.4K
CNTY icon
11042
PUT
Century Casinos
CNTY
$36M
$129K ﹤0.01%
17,900
-16,900
-49% -$158K
MFG icon
11043
Mizuho Financial
MFG
$132B
$129K ﹤0.01%
57,673
-242,142
-81% -$572K
PNF
11044
DELISTED
PIMCO New York Municipal Income Fund
PNF
$129K ﹤0.01%
+14,105
New +$131K
TKAT
11045
DELISTED
Takung Art Co., Ltd.
TKAT
$129K ﹤0.01%
77,795
+33,121
+74% +$74.6K
TCRR
11046
PUT
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$129K ﹤0.01%
44,500
+22,000
+98% +$54.3K
HOFV
11047
DELISTED
Hall of Fame Resort & Entertainment Co
HOFV
$128K ﹤0.01%
9,841
+6,865
+231% +$114K
IMPP icon
11048
CALL
Imperial Petroleum
IMPP
$217M
$128K ﹤0.01%
20,247
+15,335
+312% +$184K
KNDI
11049
PUT
Kandi Technologies Group
KNDI
$63M
$128K ﹤0.01%
53,200
-12,600
-19% -$32.8K
KULR icon
11050
CALL
KULR Technology Group
KULR
$122M
$128K ﹤0.01%
10,325
+3,637
+54% +$48.6K

Similar funds

Ken Griffin's Q2 2022 Portfolio in Review

As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.

By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.

  • Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
  • Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
  • Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
  • Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
  • Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
  • Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
  • Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.

Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.